Posted on 10/25/17
Biogen (BIIB) Q3 2017 Results - Earnings Call Transcript
Biogen, Inc. (NASDAQ:BIIB)Q3 2017 Earnings CallOctober 24, 2017 8:30 am ETExecutivesMatthew Calistri - Biogen, Inc.Michel Vounatsos - Biogen, Inc.Michael D. Ehlers, M.D., Ph.D. - Biogen, Inc.Alfred . . .
Posted on 10/25/17
Ionis Pharmaceuticals Tumbles on Biogen's Miss: Buy or Sell?
Ionis Pharmaceuticals (NASDAQ:IONS) lost 11% of its market value after commercialization partner Biogen (NASDAQ:BIIB) reported third-quarter sales of its drug, Spinraza, that failed to match industry . . .
Posted on 10/25/17
uniQure Announces Pricing of its Public Offering
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Oct. 24, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with . . .
Posted on 10/25/17
Idera Pharmaceuticals Proposes Public Offering of Common Stock
CAMBRIDGE, Mass. and EXTON, Pa, Oct. 24, 2017 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) (“Idera” or the “Company”) today announced that it intends to offer . . .
Posted on 10/23/17
athenahealth's (ATHN) CEO Jonathan Bush on Q3 2017 Results - Earnings Call Transcript
athenahealth, Inc. (NASDAQ:ATHN)Q3 2017 Results Earnings Conference CallOctober 20, 2017, 08:00 AM ETExecutivesDana Quattrochi - Executive Director, IRJonathan Bush - Chairman, President and Chief Executive OfficerJohn . . .
Posted on 10/23/17
Visterra Announces Research Collaboration, Exclusive License, and Option Agreement for Infectious Diseases with Vir Biotechnology
Visterra, Inc. today announced that it has entered into a research collaboration, exclusive license, and option agreement with Vir Biotechnology, Inc. to develop and commercialize select . . .
Posted on 10/20/17
3 Reasons Cara Therapeutics Is a Better Growth Stock Than Novavax
At one point this year, Cara Therapeutics (NASDAQ:CARA) stock was up more than 175%. Most of those gains were given up, though. The stock is now . . .
Posted on 10/20/17
Athenahealth, Inc. Cuts Financial Outlook and 9% of Its Workforce
It's a different era for athenahealth, Inc. (NASDAQ:ATHN). Investors hoped the cloud-based healthcare applications provider had begun a return to higher growth levels when the company . . .
Posted on 10/19/17
Cerveau Technologies Signs Research Agreement with Columbia University Medical Center
BOSTON--(BUSINESS WIRE)--Cerveau Technologies Inc. today announced an agreement with Columbia University Medical Center in New York, New York to support multiple projects over the next several . . .
Posted on 10/19/17
Moderna Named One of Global Biopharmaceutical Industry’s Top Employers in Science Magazine’s Annual Survey
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna Therapeutics, a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, . . .
Posted on 10/19/17
CVS Health Signs Five-Year Agreement with Anthem
CVS Health (NYSE: CVS) announced a five-year agreement with Anthem, Inc. (NYSE: ANTM) to provide services to support IngenioRx, a new pharmacy benefit manager (PBM) announced . . .
Posted on 10/17/17
Vertex Announces 10-Year, $500 Million Corporate Giving Commitment
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced a 10-year, $500 million corporate giving commitment focused on providing patient and caregiver support including access to our . . .
Posted on 10/17/17
Adventist Health System Partners with Glytec
WALTHAM, Mass.--(BUSINESS WIRE)--More than a quarter of all hospitalized patients in the U.S. have diabetes, and typically, these patients stay longer, experience more infections and have . . .
Posted on 10/17/17
Syndax Announces $25 Million Registered Direct Offering of Common Stock
Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing entinostat and SNDX-6352 in multiple cancer indications, today announced that it has agreed to sell 2,021,018 . . .
Posted on 10/17/17
Cerveau Technologies Signs Collaboration Agreement with Janssen for Novel Tau Imaging Agent
BOSTON--(BUSINESS WIRE)--Cerveau Technologies, Inc. today announced a research collaboration agreement with Janssen Pharmaceuticals, Inc. for use of [F-18]MK-6240, an investigational imaging agent to be used in . . .
Posted on 10/17/17
Dana-Farber Cancer Institute Joins the Parker Institute for Cancer Immunotherapy
The Parker Institute for Cancer Immunotherapy today announced that researchers at Dana-Farber Cancer Institute have joined its network. Dana-Farber is a leader in cancer research and . . .
Posted on 10/17/17
Amgen And Boston Children's Hospital Enter A Collaboration
Amgen (NASDAQ:AMGN) and Boston Children's Hospital today announced that they have entered into a neuroscience research collaboration aimed at identifying novel pain targets based on human . . .
Posted on 10/16/17
ArQule Announces $15.7 Million Private Placement
BURLINGTON, Mass.--(BUSINESS WIRE)--ArQule, Inc. (NASDAQ: ARQL) today announced the closing of a private placement with certain institutional investors, with leading participation by BVF Partners L.P., pursuant . . .
Posted on 10/13/17
Merrimack Commences Tender Offer for its Outstanding 4.50% Convertible Senior Notes
Merrimack Pharmaceuticals (NASDAQ: MACK) announced that it has commenced a tender offer to purchase any and all of its $25,031,000 aggregate principal amount of outstanding 4.50% . . .
Posted on 10/13/17
Biogen: Underperformance Opportunity
Please note this is only one aspect in weighing the attractiveness or non-attractiveness of the company mentioned as an investment and should not be used independently . . .
Posted on 10/12/17
Bicycle Therapeutics Recognised with Multiple Biotech Industry Awards
CAMBRIDGE, England & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) product platform, today . . .
Posted on 10/12/17
CVS Health Recognizes its 30,000 Pharmacists during American Pharmacists Month
CVS Health (NYSE:CVS) is celebrating its 30,000 pharmacists as part of American Pharmacists Month, an annual observation held every October. The company's pharmacy teams are playing . . .
Posted on 10/12/17
Flexion Therapeutics Announces Proposed Public Offering of Common Stock
BURLINGTON, Mass., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it has commenced an underwritten public offering, subject to market and . . .
Posted on 10/12/17
Rhythm Pharmaceuticals Closes IPO
BOSTON, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for treatment of . . .
Posted on 10/12/17
ImmunoGen Closes Public Offering of Common Stock
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (NASDAQ: IMGN) today announced the closing of its previously announced underwritten public offering of 16,675,000 shares of its common stock, including 2,175,000 . . .
Boston
